Results 81 to 90 of about 2,340 (179)

Towards new methodologies for the synthesis of biologically interesting 6-substituted pyrimidines and 4(3H)-pyrimidinones

ARKIVOC, 2006
Elena Petricci, Claudia Mugnaini, Marco Radi, Andrea Togninelli, Cesare Bernardini, Fabrizio Manetti, Maria Cristina Parlato, Michela Lucia Renzulli, Maddalena Alongi, Chiara Falciani, Federico Corelli, Maurizio Botta   +11 more
doaj   +1 more source

Incidence and management of pyrexia syndrome in patients treated with dabrafenib and trametinib: a retrospective study. [PDF]

Support Care Cancer
Komisarof J, Menon J, Andrzejewski A, Mulford D.   +3 more
europepmc   +1 more source

An Amazing 30-Year Journey around the DABO Family: A Medicinal Chemistry Lesson on a Versatile Class of Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. [PDF]

J Med Chem
Fabbrizi E, Chernyshov VV, Fiorentino F, Sbardella G, Ragno R, Nawrozkij M, Ivanov R, Rotili D, Mai A.   +8 more
europepmc   +1 more source

Quantitative BRAF p.V600E mutation monitoring in cerebrospinal fluid cell-free DNA reflects therapeutic response to BRAF/MEK inhibitors in papillary craniopharyngioma: a report of two cases. [PDF]

Acta Neuropathol Commun
Fudaba H, Yanagida M, Takao K, Onishi K, Matsuta H, Momii Y, Anan M, Hata N, Etoh T, Fujiki M.   +9 more
europepmc   +1 more source

PDE7 as a Precision Target: Bridging Disease Modulation and Potential PET Imaging for Translational Medicine. [PDF]

ACS Med Chem Lett
Zhao T, Liang SH.
europepmc   +1 more source

Takotsubo Syndrome Following Combination Therapy with Dabrafenib and Trametinib. [PDF]

Intern Med
Nishikawa T, Ohe S, Suzuki Y, Kobayashi M, Tateishi S, Yamane Y, Bun S, Sakamoto R, Kurokami Y, Yamamoto H, Yasui T, Fujita M.   +11 more
europepmc   +1 more source

Pathologic and radiologic response to neoadjuvant therapy in advanced differentiated thyroid cancer. [PDF]

Eur Thyroid J
Kampel L, Kampel L, Dorman A, Trejo LL, Krol K, Huber RK, Kravchenko Y, Antebi Y, Shendler G, Joshua BZ, Alon E, Warshavsky A, Horowitz G, Shilo S, Muhanna N, Finkel I.   +15 more
europepmc   +1 more source

Successful treatment of osimertinib-resistant EGFR-mutant NSCLC with acquired BRAF V600E mutation using triple combination therapy: a case report with pathological confirmation. [PDF]

World J Surg Oncol
Lin M, Chen X, Lin F, Yang Y.
europepmc   +1 more source

Scaffold-Hopping Design and Synthesis of Thieno[3,2-<i>d</i>]pyrimidines: Anticancer Activity, Apoptosis Induction, and In Silico Inhibition of CDKs. [PDF]

Int J Mol Sci
Ruzi Z, Buronov A, Nie L, Nasrullaev A, Murtazaeva Z, Kuryazov R, Zhao J, Efferth T, Aisa HA, Bozorov K.   +9 more
europepmc   +1 more source

An updated meta-analysis of head-to-head trials comparing the efficacy, safety, and adherence of mirabegron and vibegron in overactive bladder. [PDF]

Medicine (Baltimore)
Bai WZ, Zhou SY, Mou YY, Peng L, Li LL.
europepmc   +1 more source